Please Wait
Applying Filters...
menu
    • menu
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Ibogaine Hydrochloride

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Trump set to restrictions on psychedelic drug used to treat PTSD
    Trump set to restrictions on psychedelic drug used to treat PTSD

    18 Apr 2026

    // REUTERS

    https://www.reuters.com/legal/litigation/trump-set-ease-restrictions-psychedelic-drug-used-treat-ptsd-2026-04-17/

    REUTERS
    18 Apr 2026
    Share Share
    Psyence Biomed Advances Ibogaine Hcl Production, Boosts Balance
    Psyence Biomed Advances Ibogaine Hcl Production, Boosts Balance

    05 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/05/3212861/0/en/Psyence-BioMed-Achieves-Milestone-in-Natural-Ibogaine-HCl-Production-and-Strengthens-Balance-Sheet-With-No-Debt-and-12m-Cash.html

    GLOBENEWSWIRE
    05 Jan 2026
    Share Share
    Ibogaine by David Dardashti Continues to Measure Success by Analyzing Noribogaine
    Ibogaine by David Dardashti Continues to Measure Success by Analyzing Noribogaine

    16 Aug 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ibogaine-by-david-dardashti-continues-to-measure-success-by-analyzing-noribogaine-301902100.html

    PR NEWSWIRE
    16 Aug 2023
    Share Share
    Anorexia Nervosa Drug Pipeline Landscape: Therapeutic Assessment of Key Products
    Anorexia Nervosa Drug Pipeline Landscape: Therapeutic Assessment of Key Products

    20 Dec 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221220005539/en

    BUSINESSWIRE
    20 Dec 2022
    Share Share
    Universal Ibogaine Retains Shayne Nyquvest As Capital Markets Advisor
    Universal Ibogaine Retains Shayne Nyquvest As Capital Markets Advisor

    29 Apr 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/universal-ibogaine-retains-shayne-nyquvest-as-capital-markets-advisor-301536451.html

    PRNEWSWIRE
    29 Apr 2022
    Share Share
    MindMed Successfully Completes Phase 1 Clinical Trial of 18-MC
    MindMed Successfully Completes Phase 1 Clinical Trial of 18-MC

    04 Jan 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/mindmed-successfully-completes-phase-1-clinical-trial-of-18-mc-301453240.html

    PRNEWSWIRE
    04 Jan 2022
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.